(Q77766550)
Statements
Phase II trial of liposome-encapsulated doxorubicin, cyclophosphamide, and fluorouracil as first-line therapy in patients with metastatic breast cancer (English)
V Valero
R L Theriault
N Azarnia
G A Fonseca
J Willey
M Ewer
R S Walters
B Mackay
D Podoloff
D Booser
L W Lee
G N Hortobagyi